tm logo
RESIDUAL CANCER BURDEN
Dead/Abandoned
ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE

failure to respond or late response

on 02 Oct 2023

Last Applicant/ Owned by

1220 Blalock Rd., Suite 300

Houston

TX

77055

Serial Number

97205532 filed on 06th Jan 2022

Registration Number

N/A

Correspondent Address

Naira Simmons

Naira Simmons

32 School Ln

Scarsdale NY 10583

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

RESIDUAL CANCER BURDEN

Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Providing a website via a global computer network featuring a residual cancer burden calculator


First Use Date in General

01st Oct 2007

First Use Date in Commerce

01st Oct 2007

Class [044]
Medical, Beauty & Agricultural Services


Medical testing, prediction and assessment for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; Providing medical, assessment and prediction information to medical professionals in the field of cancer and disease classification; Providing medical information, assessment and prediction to medical professionals on sensitivities of cancers to hormones and/or hormone therapies


First Use Date in General

01st Oct 2007

First Use Date in Commerce

01st Oct 2007

Class [042]
Computer & Software Services & Scientific Services


Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development of pharmaceuticals for the assessment and prediction of effectiveness of treatment of age-related diseases and cancer; Assessment and predictions of medical diagnosis and treatment of cancer; Providing information about medical research, predictions and assessments in the field of cancer


First Use Date in General

01st Oct 2007

First Use Date in Commerce

01st Oct 2007

Class [010]
Medical Instrument Products


Medical diagnostic apparatus for assessing and predicting recurrence of cancer cells incorporating recorded operating system software


First Use Date in General

01st Oct 2007

First Use Date in Commerce

01st Oct 2007

Specimens


RESIDUAL CANCER BURDEN specimen

Mark Details


Serial Number

No 97205532

Mark Type

No Service Mark

Attorney Docket Number

No 17947.T001US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
02th Oct 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
02th Oct 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
25th May 2023NON-FINAL ACTION WRITTEN
25th May 2023NON-FINAL ACTION E-MAILED
25th May 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
27th Apr 2023USE AMENDMENT FILED
27th Apr 2023AMENDMENT TO USE PROCESSING COMPLETE
27th Apr 2023TEAS/EMAIL CORRESPONDENCE ENTERED
26th Apr 2023TEAS AMENDMENT OF USE RECEIVED
26th Apr 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED